Challenges and innovations in CAR-T cell therapy: a comprehensive analysis.

Front Oncol · 2024 · PMC11196618 · PMID 38919533

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Although the occurrence of HS/HLH is uncommon, it is highly significant in CAR-T cell therapy, as this condition can cause serious clinical complications.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.